|
1
|
Kuwahara A, Takachi R, Tsubono Y, Sasazuki
S, Inoue M and Tsugane S; JPHC Study Group: Socioeconomic status
and gastric cancer survival in Japan. Gastric Cancer. 13:222–230.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Krejs GJ: Gastric cancer: Epidemiology and
risk factors. Dig Dis. 28:600–603. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tan IB, Ng I, Tai WM and Tan P:
Understanding the genetic basis of gastric cancer: recent advances.
Expert Rev Gastroenterol Hepatol. 6:335–341. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ola MS, Nawaz M and Ahsan H: Role of Bcl-2
family proteins and caspases in the regulation of apoptosis. Mol
Cell Biochem. 351:41–58. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Llambi F and Green DR: Apoptosis and
oncogenesis: Give and take in the BCL-2 family. Curr Opin Genet
Dev. 21:12–20. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weyhenmeyer B, Murphy AC, Prehn JH and
Murphy BM: Targeting the anti-apoptotic Bcl-2 family members for
the treatment of cancer. Exp Oncol. 34:192–199. 2012.PubMed/NCBI
|
|
7
|
Davids MS and Letai A: Targeting the
B-cell lymphoma/leukemia 2 family in cancer. J Clin Oncol.
30:3127–3135. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thomas LW, Lam C and Edwards SW: Mcl-1;
the molecular regulation of protein function. FEBS Lett.
584:2981–2989. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Akgul C: Mcl-1 is a potential therapeutic
target in multiple types of cancer. Cell Mol Life Sci.
66:1326–1336. 2009. View Article : Google Scholar
|
|
10
|
Mandelin AM II and Pope RM: Myeloid cell
leukemia-1 as a therapeutic target. Expert Opin Ther Targets.
11:363–373. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Perciavalle RM and Opferman JT: Delving
deeper: MCL-1’s contributions to normal and cancer biology. Trends
Cell Biol. 23:22–29. 2013. View Article : Google Scholar
|
|
12
|
Zhang T, Zhao C, Luo L, Zhao H, Cheng J
and Xu F: The expression of Mcl-1 in human cervical cancer and its
clinical significance. Med Oncol. 29:1985–1991. 2012. View Article : Google Scholar
|
|
13
|
Luo L, Zhang T, Liu H, Lv T, Yuan D, Yao
Y, Lv Y and Song Y: miR-101 and Mcl-1 in non-small-cell lung
cancer: Expression profile and clinical significance. Med Oncol.
29:1681–1686. 2012. View Article : Google Scholar
|
|
14
|
Henderson-Jackson EB, Helm J, Ghayouri M,
Hakam A, Nasir A, Leon M, Bui M, Yeatman T and Coppola D:
Correlation between Mcl-1 and pAKT protein expression in colorectal
cancer. Int J Clin Exp Pathol. 3:768–774. 2010.PubMed/NCBI
|
|
15
|
Likui W, Qun L, Wanqing Z, Haifeng S,
Fangqiu L and Xiaojun L: Prognostic role of myeloid cell leukemia-1
protein (Mcl-1) expression in human gastric cancer. J Surg Oncol.
100:396–400. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Maeta Y, Tsujitani S, Matsumoto S,
Yamaguchi K, Tatebe S, Kondo A, Ikeguchi M and Kaibara N:
Expression of Mcl-1 and p53 proteins predicts the survival of
patients with T3 gastric carcinoma. Gastric Cancer. 7:78–84. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tsujitani S, Saito H, Wakatsuki T,
Ikeguchi M, Shirabe K, Morita M, Kakeji Y, Yano T and Maehara Y:
Relationship between expression of apoptosis-related proteins and
the efficacy of postoperative chemotherapy in patients with T3
gastric cancer. Surg Today. 42:225–232. 2012. View Article : Google Scholar
|
|
18
|
Steinestel K, Eder S, Schrader AJ and
Steinestel J: Clinical significance of epithelial-mesenchymal
transition. Clin Transl Med. 3:172014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Davis FM, Stewart TA, Thompson EW and
Monteith GR: Targeting EMT in cancer: Opportunities for
pharmacological intervention. Trends Pharmacol Sci. 35:479–488.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Peng Z, Wang CX, Fang EH, Wang GB and Tong
Q: Role of epithelial-mesenchymal transition in gastric cancer
initiation and progression. World J Gastroenterol. 20:5403–5410.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guarino M, Rubino B and Ballabio G: The
role of epithelial-mesenchymal transition in cancer pathology.
Pathology. 39:305–318. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Natalwala A, Spychal R and Tselepis C:
Epithelial-mesenchymal transition mediated tumourigenesis in the
gastrointestinal tract. World J Gastroenterol. 14:3792–3797. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Townson JL and Chambers AF: Dormancy of
solitary metastatic cells. Cell Cycle. 5:1744–1750. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ombrato L and Malanchi I: The EMT
universe: space between cancer cell dissemination and metastasis
initiation. Crit Rev Oncog. 19:349–361. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Findlay VJ, Wang C, Watson DK and Camp ER:
Epithelial-to-mesenchymal transition and the cancer stem cell
phenotype: Insights from cancer biology with therapeutic
implications for colorectal cancer. Cancer Gene Ther. 21:181–187.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu X and Fan D: The
epithelial-mesenchymal transition and cancer stem cells: functional
and mechanistic links. Curr Pharm Des. 21:1279–1291. 2015.
View Article : Google Scholar
|
|
28
|
Lindsey S and Langhans SA: Crosstalk of
oncogenic signaling pathways during epithelial-mesenchymal
transition. Front Oncol. 4:3582014. View Article : Google Scholar
|
|
29
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: New insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
